Ophthamology Innovation Summit Index
The OIS Index was introduced in October 2016 at OIS@AAO with the purpose of tracking the performance of the ophthalmology sector. The components of the OIS Index are publicly traded small- and mid-cap growth companies in ophthalmology in the US that derive at least half of their value from ophthalmic products and technology. Company market caps range from $10 million to $9 billion, with a median of $250 million. More information can be found on the OIS home page.